cgp 36742 has been researched along with oxiracetam in 2 studies
| Studies (cgp 36742) | Trials (cgp 36742) | Recent Studies (post-2010) (cgp 36742) | Studies (oxiracetam) | Trials (oxiracetam) | Recent Studies (post-2010) (oxiracetam) |
|---|---|---|---|---|---|
| 63 | 3 | 2 | 173 | 22 | 39 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Borkowski, J; Ducret, T; Hengerer, B; Mondadori, C | 1 |
| Borkowski, J; Möbius, HJ; Mondadori, C | 1 |
2 other study(ies) available for cgp 36742 and oxiracetam
| Article | Year |
|---|---|
Delayed emergence of effects of memory-enhancing drugs: implications for the dynamics of long-term memory.
Topics: Animals; Arecoline; Captopril; Dose-Response Relationship, Drug; GABA-A Receptor Antagonists; Male; Memory; Mice; Organophosphorus Compounds; Psychotropic Drugs; Pyrrolidines; Time Factors | 1994 |
The GABAB receptor antagonist CGP 36,742 and the nootropic oxiracetam facilitate the formation of long-term memory.
Topics: Animals; Brain; Dose-Response Relationship, Drug; Female; GABA Antagonists; Long-Term Potentiation; Mental Recall; Mice; Mice, Inbred Strains; Nootropic Agents; Organophosphorus Compounds; Pyrrolidines; Receptors, GABA-B | 1996 |